共 11 条
[1]
[2]
Valproic acid suppresses Nrf2/Keap1 dependent antioxidant protection through induction of endoplasmic reticulum stress and Keap1 promoter DNA demethylation in human lens epithelial cells[J] Periyasamy Palsamy;Keshore R. Bidasee;Toshimichi Shinohara Experimental Eye Research 2014,
[3]
SIRT1 and other sirtuins in metabolism[J] Hung-Chun Chang;Leonard Guarente Trends in Endocrinology & Metabolism 2014,
[4]
Adverse drug reactions induced by valproic acid[J] Radu M. Nanau;Manuela G. Neuman Clinical Biochemistry 2013,
[5]
Molecular and Therapeutic Potential and Toxicity of Valproic Acid[J] Sébastien Chateauvieux;Franck Morceau;Mario Dicato;Marc Diederich;Ronald E. Baynes Journal of Biomedicine and Biotechnology 2010,
[6]
Participation of lipid transport and fatty acid metabolism in valproate sodium-induced hepatotoxicity in HepG2 cells[J] Qiaoli Ji;Xiaolian Shi;Rong Lin;Youhua Mao;Xiaogang Zhai;Qinqin Lin;Jiye Zhang Toxicology in Vitro 2010,
[7]
VPA-related axial skeletal defects and apoptosis: A proposed event cascade[J] Francesca Di Renzo;Maria Luisa Broccia;Erminio Giavini;Elena Menegola Reproductive Toxicology 2009,
[8]
A Brazilian galactosialidosis patient given renal transplantation: A case report[J] A. Kiss;P. R. G. Zen;V. Bittencourt;G. A. Paskulin;R. Giugliani;A. d’Azzo;I. V. Schwartz Journal of Inherited Metabolic Disease 2008,
[9]
Active Regulator of SIRT1 Cooperates with SIRT1 and Facilitates Suppression of p53 Activity[J] Eun-Joo Kim;Jeong-Hoon Kho;Moo-Rim Kang;Soo-Jong Um Molecular Cell 2007,
[10]
ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes[J] TracyGlauser;ElinorBen‐Menachem;BlaiseBourgeois;AvitalCnaan;DavidChadwick;CarlosGuerreiro;ReettaKalviainen;RichardMattson;EmilioPerucca;TorbjornTomson Epilepsia 2006,

